Clinical Scientist
ClairoFull Time
Senior (5 to 8 years), Expert & Leadership (9+ years)
Candidates should possess an MS, GC, or PhD degree in Cancer Genetics, Human Genetics, or Biological Sciences. Prior experience in a diagnostic laboratory, clinical report writing, and familiarity with human mutation databases, genome browsers, and HGVS nomenclature is preferred, with oncology experience being strongly preferred. Essential skills include utmost attention to detail, excellent communication and writing abilities, the capacity to accurately follow formal documentation and protocols, and the ability to work effectively both individually and in a group setting, with flexibility to adjust priorities as needed.
The Variant Scientist will accurately classify somatic and germline variants for various NGS sequencing types, analyze clinical molecular data using in-house software tools, and interpret scientific literature to curate relevant findings. Responsibilities include summarizing genetic test results to generate high-quality clinical reports, performing critical quality control functions for molecular reports in compliance with quality management programs and standard operating procedures, and supporting improvements for current assays and processes. The role also involves curating variants, genes, and diseases for scientific and clinical relevance, and potentially training junior team members.
AI-driven healthcare data analysis platform
Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.